Impact of NMES, Aerobic, and Resistance Exercise on Glycemic Control in Older Adults With Type 2 Diabetes
NMES4GliCon
Effects of Neuromuscular Electrical Stimulation and Aerobic and Resistance Exercise on Glycemic Control in Older Adults With Type 2 Diabetes
1 other identifier
interventional
105
0 countries
N/A
Brief Summary
This study aims to evaluate the effects of neuromuscular electrical stimulation (NMES), aerobic and resistance exercise, and health literacy intervention on fasting glucose levels and quality of life in older adults with type 2 diabetes (T2DM). Given the growing prevalence of T2DM in aging populations and the associated health risks, identifying effective interventions is crucial. The randomized controlled trial (RCT) will include participants aged 60+ with T2DM, randomly assigned to one of three groups: NMES, structured exercise, or a health literacy control group. Outcomes will be assessed at baseline, post-intervention (12 weeks), and follow-up (30, 60, and 90 days). The primary outcome is fasting glucose levels, while secondary outcomes include adherence, treatment satisfaction, and quality of life. This study seeks to provide evidence on alternative approaches for glycemic control in elderly individuals, particularly those with limited physical activity capacity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2025
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 26, 2025
CompletedFirst Posted
Study publicly available on registry
March 4, 2025
CompletedStudy Start
First participant enrolled
May 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2026
CompletedApril 3, 2025
March 1, 2025
1 year
February 26, 2025
March 28, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Fasting Blood Glucose Levels
Measurement of fasting blood glucose levels using standardized blood collection and analysis.
Baseline, after 12 weeks of intervention, and at follow-ups (30, 60, and 90 days post-intervention).
Glycemic Control (HbA1c)
Measurement of hemoglobin A1c (HbA1c) levels using a blood test to assess long-term glycemic control.
Baseline, after 12 weeks of intervention, and at follow-ups (30, 60, and 90 days post-intervention).
Secondary Outcomes (3)
Health-Related Quality of Life
Baseline, after 12 weeks of intervention, and at follow-ups (30, 60, and 90 days post-intervention).
Treatment Adherence Rates
After 12 weeks of intervention.
Participant Satisfaction
After 12 weeks of intervention.
Other Outcomes (2)
Baseline Physical Activity Level
Baseline.
Baseline Physical Fitness Level
Baseline.
Study Arms (3)
NMES Intervention Group
EXPERIMENTALParticipants in this arm will receive neuromuscular electrical stimulation (NMES) for 30 minutes, three times per week, for 12 weeks. The sessions will be supervised by a physical therapist. NMES will be applied to large muscle groups, such as the quadriceps, using specific parameters (5 Hz frequency, 400 μs pulse duration, 4 seconds stimulation on, 12 seconds rest off), adjusted to the maximum tolerable intensity for each participant. This group aims to evaluate the effect of NMES on glycemic control and quality of life in older adults with type 2 diabetes mellitus (T2DM).
Exercise Intervention Group
EXPERIMENTALParticipants in this arm will engage in a combined aerobic and resistance exercise program three times per week for 12 weeks. The program will consist of 20 minutes of aerobic exercise (60-75% of maximum heart rate or moderate perceived effort) and 20 minutes of resistance training (50-70% of one-repetition maximum, focusing on large muscle groups). This exercise program will be supervised by a physical therapist and adapted to the participants' physical capabilities. This arm aims to compare the effects of exercise on glycemic control and quality of life in older adults with T2DM.
Health Education Group
ACTIVE COMPARATORParticipants in this arm will receive health education focused on diabetes management, including lifestyle changes and strategies for improving glycemic control. The sessions will be led by trained healthcare providers and will focus on diet, exercise, and self-management strategies. The goal is to assess the effects of health education on fasting glucose levels and quality of life in older adults with T2DM.
Interventions
Participants will receive NMES application for 30 minutes, three times a week, over a period of 12 weeks. The sessions will be supervised by a physiotherapist. Large muscle groups (quadriceps) will be used, with the following current parameters: frequency of 5 Hz, pulse width of 400 μs, 4 seconds of stimulation (on) for 12 seconds of rest (off), and intensity adjusted to the maximum tolerable level for the patient. These parameters are based on studies that have shown significant improvements in glycemic control and insulin sensitivity, especially in older adults with type 2 diabetes.
This group will participate in an exercise program combining aerobic and resistance activities, performed three times per week for 12 weeks. The activities will be adapted to the participants' physical capabilities and supervised by a physiotherapist. The program follows the international recommendations and it includes a 5-minute warm-up with flexibility exercises, 20 minutes of aerobic exercise at 60-75% of maximum heart rate or moderate perceived exertion, 20 minutes of resistance exercise at 50-70% of one-repetition maximum (1RM) focusing on large muscle groups (10-15 repetitions per exercise, 1-3 sets), and a 5-minute cool-down with static stretching and breathing exercises for relaxation.
Participants will receive educational sessions on diabetes management, the role of exercise in glycemic control, and strategies to enhance adherence to physical activity.
Eligibility Criteria
You may qualify if:
- Diagnosed with Type 2 Diabetes Mellitus (T2DM).
- Aged 60 years or older.
- Sufficient cognitive ability to understand study instructions.
- Institutionalized in nursing homes or similar settings.
- Willing and able to provide informed consent.
You may not qualify if:
- Severe cardiovascular diseases (e.g., heart failure, recent myocardial infarction).
- Musculoskeletal conditions that prevent exercise participation (e.g., severe arthritis, unhealed fractures).
- Intensive insulin therapy with high risk of hypoglycemia or significant glycemic control issues.
- Participation in other clinical trials that could interfere with this study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Carlos Tavareslead
- University of Salamancacollaborator
- Escola Superior de Tecnologia da Saúde de Coimbracollaborator
- Instituto Piagetcollaborator
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Effects of Neuromuscular Electrical Stimulation and Aerobic and Resistance Exercise on Glycemic Control in Older Adults with Type 2 Diabetes: A Randomized Controlled Trial
Study Record Dates
First Submitted
February 26, 2025
First Posted
March 4, 2025
Study Start
May 1, 2025
Primary Completion
May 1, 2026
Study Completion
May 1, 2026
Last Updated
April 3, 2025
Record last verified: 2025-03